Raymond S Douglas MD PhD Professor of Surgery, Division of Ophthalmology Director of the Orbital and Thyroid Eye Disease Program Cedars Sinai Medical Center

Monoclonal Antibody Offers Hope For Patients With Thyroid Eye Disease

MedicalResearch.com Interview with:

Raymond S Douglas MD PhD Professor of Surgery, Division of Ophthalmology Director of the Orbital and Thyroid Eye Disease Program Cedars Sinai Medical Center

Dr. Douglas

Raymond S Douglas MD PhD
Professor of Surgery, Division of Ophthalmology
Director of the Orbital and Thyroid Eye Disease Program
Cedars Sinai Medical Center

MedicalResearch.com: What is the background for this study?

Response: Thyroid eye disease (TED) is a debilitating disease that affects all aspects of a patients life. It is often associated with Graves’ disease and thyroid abnormalities. TED causes profound bulging of the eyes impairing vision, causing eye pain and facial disfigurement.

MedicalResearch.com: What are the main findings?

Response: The article details the use of teprotumumab, a human monoclonal antibody which binds and inhibits the IGF-1R (insulin like growth factor 1 receptor.) This drug was tested in patients with thyroid eye disease and found to effectively reverse the proptosis, inflammation and diplopia associated with the disease. The drug was rapidly effective achieving response in two doses or 6 weeks of administration. The drug was also well tolerated.

This study demonstrates that medical treatment with teprotumumab is effective at reversing the manifestations of disease, providing new hope for patients

MedicalResearch.com: What should readers take away from your report?

Response: Given the profound results of the study, I believe we are on the verge of a new paradigm in the treatment of this disease.

Disclosures: Dr. Douglas is consultant for Horizon therapeutics 2019 2020

 

Citation:

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Raymond S. Douglas, M.D., Ph.D., George J. Kahaly, M.D., Ph.D., Amy Patel, M.D., Saba Sile, M.D., Elizabeth H.Z. Thompson, Ph.D., Renee Perdok, M.S., James C. Fleming, M.D., Brian T. Fowler, M.D., Claudio Marcocci, M.D., Michele Marinò, M.D., Alessandro Antonelli, M.D., Roger Dailey, M.D.,

January 23, 2020
N Engl J Med 2020; 382:341-352
DOI: 10.1056/NEJMoa1910434 

JOIN OUR EMAIL LIST

We respect your privacy and will never share your details.

Last Modified: Jan 23, 2020 @ 1:20 am 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.